New Publications from the Mass General Department of Psychiatry – October 25, 2024

October 25, 2024
MGH Psychiatry News
From the clinicians and researchers in our department, a list of our most recent publications.

The Mass General Department of Psychiatry encompasses more than 60 specialty integrated clinical and research programs.  Our wide-ranging research portfolio spans clinical and basic research covering virtually every major psychiatric disorder, as well as the psychiatric consequences of medical illness. 

These initiatives have led to notable expansions in genetics, neuroimaging and basic neuroscience, and this model of cross-talk between clinical care and science has consistently led to research advances that inform and advance clinical care.


 

iVR-fNIRS: studying brain functions in a fully immersive virtual environment.

Peng K, Moussavi Z, Karunakaran KD, Borsook D, Lesage F, Nguyen DK.  Neurophotonics. 2024 Apr;11(2):020601. 

 

Transcranial focused ultrasound of the amygdala modulates fear network activation and connectivity.

Chou T, Deckersbach T, Guerin B, Sretavan Wong K, Borron BM, Kanabar A, Hayden AN, Long MP, Daneshzand M, Pace-Schott EF, Dougherty DD.  Brain Stimul. 2024 Mar-Apr;17(2):312-320. 

 

Neural and Cognitive Predictors of Stimulant Treatment Efficacy in Medication-Naïve ADHD Adults: A Pilot Diffusion Tensor Imaging Study.

Hung Y, Green A, Kelberman C, Gaillard S, Capella J, Rudberg N, Gabrieli JDE, Biederman J, Uchida M.  J Atten Disord. 2024 Mar;28(5):936-944. 

 

Experiencing hallucinations in daily life: The role of metacognition.

Wright AC, Palmer-Cooper E, Cella M, McGuire N, Montagnese M, Dlugunovych V, Liu CJ, Wykes T, Cather C.  Schizophr Res. 2024 Mar;265:74-82. 

 

Linking brain structure, cognition, and sleep: insights from clinical data.

Wei R, Ganglberger W, Sun H, Hadar PN, Gollub RL, Pieper S, Billot B, Au R, Eugenio Iglesias J, Cash SS, Kim S, Shin C, Westover MB, Joseph Thomas R.  Sleep. 2024 Feb 8;47(2):zsad294. 

 

Optimizing the Implementation of a Lifestyle Dementia Prevention Intervention for Older Patients in an Academic Healthcare System.

Mace RA, Lyons C, Cohen JE, Ritchie C, Bartels S, Okereke OI, Hoeppner BB, Brewer JA, Vranceanu AM.  J Alzheimers Dis. 2024;100(4):1237-1259. 

 

Machines, mathematics, and modules: the potential to provide real-time metrics for pain under anesthesia.

Peng K, Karunakaran KD, Green S, Borsook D.  Neurophotonics. 2024 Jan;11(1):010701. 

 

Brain stimulation targets for chronic pain: Insights from meta-analysis, functional connectivity and literature review.

Kong Q, Li T, Reddy S, Hodges S, Kong J.  Neurotherapeutics. 2024 Jan;21(1):e00297. 

   

Rethinking clinical trials in restless legs syndrome: A roadmap.

Garcia-Borreguero D, Black J, Earley CJ, Fulda S, Högl B, Manconi M, Ondo W, Roth T, Trenkwalder C, Winkelman JW; International Restless Legs Syndrome Study Group (IRLSSG).  Sleep Med Rev. 2024 Oct;77:101978. 

 

Intention to quit or reduce e-cigarettes, cannabis, and their co-use among a school-based sample of adolescents.

Liu J, Knoll SJ, Pascale MP, Gray CA, Bodolay A, Potter KW, Gilman J, Eden Evins A, Schuster RM.  Addict Behav. 2024 Oct;157:108101. 

 

Second Opinions for Diagnoses of Psychotic Disorders: Delivering Stage-Specific Recommendations.

Lim C, Donovan AL, Freudenreich S, Cather C, Maclaurin S, Freudenreich O.  Psychiatr Serv. 2024 Oct 1;75(10):1035-1038. 

 

Do tobacco regulatory and economic factors influence smoking cessation outcomes? A post-hoc analysis of the multinational EAGLES randomised controlled trial.

Daniel B, Lawrence DE, McKenna BS, Saccone P, McRae T, Evins AE, Anthenelli RM.  BMJ Open. 2024 Sep 20;14(9):e079092. 

 

Improvement in self-reported, but not actigraphic, sleep measures with suvorexant in people with well-controlled Restless Legs Syndrome and persistent insomnia.

Winkelman JW, Zackon J, Kilty A.  Sleep Med. 2024 Sep 8;124:30-37. 

 

Racial Differences in Nicotine Reduction: Pooled Results from Two Double-Blind Randomized Controlled Trials.

Lin W, Krebs NM, Zhu J, Horn K, Foulds J, Evins AE, Muscat JE.  J Racial Ethn Health Disparities. 2024 Sep 4. 

 

Year-Long Cannabis Use for Medical Symptoms and Brain Activation During Cognitive Processes.

Burdinski DCL, Kodibagkar A, Potter K, Schuster RM, Evins AE, Ghosh SS, Gilman JM.  JAMA Netw Open. 2024 Sep 3;7(9):e2434354. 

 

Vaping in Youth.

Winickoff JP, Evins AE, Levy S.  JAMA. 2024 Sep 3;332(9):749-750. 

 

Using Community-Based Participatory Research to Conduct a Collaborative Needs Assessment of Mental Health Service Users: Identifying Research Questions and Building Academic-Community Trust.

Delman J, Arntz D, Whitman A, Skiest H, Kritikos K, Alves P, Chambers V, Markley R, Martinez J, Piltch C, Whitney-Sarles S, London J, Shtasel D, Cather C.  Health Promot Pract. 2024 Sep;25(5):855-864. 

 

Comparison of autonomic reactivity to trauma and nightmare imagery: A Pilot Study.

McGrory CM, Kram Mendelsohn A, Pineles SL, Lasko NB, Ivkovic V, Moon M, Cetinkaya D, Bazer O, Fortier E, Kelly A, Bragdon LB, Arditte Hall KA, Tanev K, Orr SP, Pace-Schott EF.  Sleep Adv. 2024 Aug 13;5(1):zpae060. 

 

Implementation of Community Health Worker Support for Tobacco Cessation: A Mixed-Methods Study.

Foo CYS, Potter K, Nielsen L, Rohila A, Maravic MC, Schnitzer K, Pachas GN, Levy DE, Reyering S, Thorndike AN, Cather C, Evins AE.  Psychiatr Serv. 2024 Aug 9:appips20240044. 

 

Disparities in Exposure to Tobacco on Television or Streaming Platforms.

Onyeaka HK, Chido-Amajuoyi OG, Sokale I, Ajayi KV, Evins AE, Amonoo HL, Shete S.  JAMA Netw Open. 2024 Aug 1;7(8):e2427781. 

 

Intoxication due to Δ9-tetrahydrocannabinol is characterized by disrupted prefrontal cortex activity.

Karunakaran KD, Pascale M, Ozana N, Potter K, Pachas GN, Evins AE, Gilman JM.  Neuropsychopharmacology. 2024 Aug;49(9):1481-1490. 

 

ENIGMA-Chronic Pain: a worldwide initiative to identify brain correlates of chronic pain.

Quidé Y, Jahanshad N, Andoh J, Antoniou G, Apkarian AV, Ashar YK, Badran BW, Baird CL, Baxter L, Bell TR, Blanco-Hinojo L, Borckardt J, Cheung CL, Ciampi de Andrade D, Couto BA, Cox SR, Cruz-Almeida Y, Dannlowski U, De Martino E, de Tommaso M, Deus J, Domin M, Egorova-Brumley N, Elliott J, Fanton S, Fauchon C, Flor H, Franz CE, Gatt JM, Gerdhem P, Gilman JM, Gollub RL, Govind V, Graven-Nielsen T, Håkansson G, Hales T, Haswell C, Heukamp NJ, Hu L, Huang L, Hussain A, Jensen K, Kircher T, Kremen WS, Leehr EJ, Lindquist M, Loggia ML, Lotze M, Martucci KT, Meeker TJ, Meinert S, Millard SK, Morey RA, Murillo C, Nees F, Nenadic I, Park HRP, Peng X, Ploner M, Pujol J, Robayo LE, Salan T, Seminowicz DA, Serian A, Slater R, Stein F, Stevens J, Strauss S, Sun D, Vachon-Presseau E, Valdes-Hernandez PA, Vanneste S, Vernon M, Verriotis M, Wager TD, Widerstrom-Noga E, Woodbury A, Zeidan F, Bhatt RR, Ching CRK, Haddad E, Thomopoulos SI, Thompson PM, Gustin SM.  Pain. 2024 Jul 26. 

 

Innovative outpatient treatment for veterans and service members and their family members.

Hoover GG, Teer A, Lento R, Ward P, Zakarian RJ, Tinney W, Sanders W, Echevarria K, Bonvie J, Dunford K, Covitz J, Tanev KS.  Front Psychiatry. 2024 Jul 24;15:1377433. 

 

Pharmacologic Management of the Sequelae of Traumatic Brain Injuries.

Matta SE, LaCroix C, Tanev K, Stern TA.  Prim Care Companion CNS Disord. 2024 Jul 16;26(4):23f03670.

 

Share this with your network: